Clinical trial
Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder
NCT00026585 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00026585 |
|---|---|
| Title | Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder |
| Official title | A Double-Blind Study Examining the Efficacy of the Protein Kinase C Inhibitor Tamoxifen in the Treatment of Acute Mania |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Tamoxifen |
| Enrollment | 50 |
| Start date | Nov 9, 2001 |
| Completion | Nov 2, 2007 |
| First posted | Nov 12, 2001 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: